TY - JOUR
T1 - Next-generation sequencing and protein mass spectrometry for the comprehensive analysis of human cellular and serum antibody repertoires
AU - Lavinder, Jason J.
AU - Horton, Andrew P.
AU - Georgiou, George
AU - Ippolito, Gregory C.
N1 - Publisher Copyright:
© 2014.
PY - 2015/2/1
Y1 - 2015/2/1
N2 - Recent developments of high-throughput technologies are enabling the molecular-level analysis and bioinformatic mining of antibody-mediated (humoral) immunity in humans at an unprecedented level. These approaches explore either the sequence space of B-cell receptor repertoires using next-generation deep sequencing (BCR-seq), or the amino acid identities of antibody in blood using protein mass spectrometry (Ig-seq), or both. Generalizable principles about the molecular composition of the protective humoral immune response are being defined, and as such, the field could supersede traditional methods for the development of diagnostics, vaccines, and antibody therapeutics. Three key challenges remain and have driven recent advances: (1) incorporation of innovative techniques for paired BCR-seq to ascertain the complete antibody variable-domain VH:VL clonotype, (2) integration of proteomic Ig-seq with BCR-seq to reveal how the serum antibody repertoire compares with the antibody repertoire encoded by circulating B cells, and (3) a demand to link antibody sequence data to functional meaning (binding and protection).
AB - Recent developments of high-throughput technologies are enabling the molecular-level analysis and bioinformatic mining of antibody-mediated (humoral) immunity in humans at an unprecedented level. These approaches explore either the sequence space of B-cell receptor repertoires using next-generation deep sequencing (BCR-seq), or the amino acid identities of antibody in blood using protein mass spectrometry (Ig-seq), or both. Generalizable principles about the molecular composition of the protective humoral immune response are being defined, and as such, the field could supersede traditional methods for the development of diagnostics, vaccines, and antibody therapeutics. Three key challenges remain and have driven recent advances: (1) incorporation of innovative techniques for paired BCR-seq to ascertain the complete antibody variable-domain VH:VL clonotype, (2) integration of proteomic Ig-seq with BCR-seq to reveal how the serum antibody repertoire compares with the antibody repertoire encoded by circulating B cells, and (3) a demand to link antibody sequence data to functional meaning (binding and protection).
UR - http://www.scopus.com/inward/record.url?scp=84911909440&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84911909440&partnerID=8YFLogxK
U2 - 10.1016/j.cbpa.2014.11.007
DO - 10.1016/j.cbpa.2014.11.007
M3 - Review article
C2 - 25461729
AN - SCOPUS:84911909440
SN - 1367-5931
VL - 24
SP - 112
EP - 120
JO - Current Opinion in Chemical Biology
JF - Current Opinion in Chemical Biology
ER -